Baotou Dongbao Bio-Tech Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 706.04 million compared to CNY 412.27 million a year ago. Revenue was CNY 706.04 million compared to CNY 412.27 million a year ago.

Net income was CNY 87.78 million compared to CNY 13.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.1479 compared to CNY 0.0248 a year ago. Diluted earnings per share from continuing operations was CNY 0.1479 compared to CNY 0.0248 a year ago.